tert-Butyl 4-(3-methoxybenzamido)piperidine-1-carboxylate, 95.0%, 1g

2-Bromo-9,9-difluoro-9H-fluorene, 98%, 100mg

2-(2,6-Dioxopiperidin-3-yl)-1-oxoisoindoline-5-carbaldehyde, 98%, 100mg

Caspase-1 Inhibitor Z-Val-Ala-DL-Asp-fluoromethylketone, 98+%, 5mg

Fmoc-N-Me-Thr(tBu)-OH, >99%, 5g

2-Fluoro-�-nitrostyrene, 98.0%, 1g

(3-Chloro-5-(methylcarbamoyl)phenyl)boronic acid, 95.0%, 5g

(R)-N-(1-(7-(But-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)-2,2,2-trifluoroacetamide (Linagliptin Impurity), 97%, 50mg

2-Ethylhexyl 4-(Dimethylamino)benzoate>98.0%(GC)(T)100mL

2-(2-Bromo-4-(tert-butyl)phenoxy)acetic acid, 98%, 1g

4-Cyanobenzohydrazide, 95.0%, 25g

[2-Chloro-5-methyl-4-(methylsulfonyl)phenyl]hydrazine, 95.0%, 1g

1,3-Dibromo-5-fluoro-2-(phenylmethoxy)benzene, 98%, 10g